偷家战术,无码激情AAAAA片-区区,A∨在线视频播放,JZZIJZZIJ在线观看亚洲熟妇

加拿大Akela Pharma
Akela Pharma Inc. (蒙特婁，Montreal)，一家專(zhuān)精于開(kāi)發(fā)吸入劑及止痛劑的藥物開(kāi)發(fā)公司
A world leader in pharmaceutical development
Akela Pharma has emerged as one of the world leaders for inhaled therapeutics.Its pipeline includes inhalation therapies for pain management, growth hormone deficiencies, asthma and abuse deterrent formulations.
Akela Pharma is an integrated drug development company focused on developing therapies for the growing multi-billion dollar inhalation, pain and CNS markets. Its lead product, for the treatment of breakthrough cancer pain, is a fast-acting Fentanyl formulation delivered using the Company's TAIFUN(R) dry powder inhaler platform. Its pipeline also includes therapeutics for asthma, COPD, growth hormone deficiencies and controlled substance abuse deterrent formulations.

Akela's common shares trade on The Toronto Stock Exchange ("TSX") under the symbol "AKL" with 82.3 million shares outstanding.